• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Senate committee to vote on Dr. Oz’s nomination to run the Centers for Medicare and Medicaid Services

by March 25, 2025
written by March 25, 2025

The Senate Committee on Finance is set to vote later Tuesday afternoon on whether to advance President Donald Trump’s pick to lead the Centers for Medicare and Medicaid Services, Dr. Mehmet Oz, to a full Senate confirmation vote. 

The vote follows two hearings by the committee that probed Oz over his plans for the federal healthcare programs, his views on abortion, potential conflicts of interest in the healthcare industry and more.   

If confirmed, Oz would be in charge of nearly $1.5 trillion in federal healthcare spending. Medicare, a federal healthcare program for seniors aged 65 and up, currently provides coverage for about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, which assists people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov.

A former heart surgeon who saw his fame rise through his appearances on daytime TV and 13 seasons of ‘The Dr Oz Show,’ Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He ultimately lost to John Fetterman, then the state’s lieutenant governor. 

Oz graduated from Harvard and received medical and business degrees from the University of Pennsylvania.

As the administrator of CMS, Oz would make decisions related to how the government covers procedures, hospital stays and medication within the federal healthcare programs, as well as the reimbursement rates at which healthcare providers get paid for their services.

Earlier this month, Trump’s pick to lead the NIH and FDA, Dr. Jay Bhattacharya and Dr. Marty Makary, respectively, were also approved in committee and are awaiting full confirmation votes in the Senate. 

Around the same time that Bhattacharya and Makary won committee approval, Trump withdrew his nomination of former Florida Rep. David Weldon to run the CDC, over fears he did not have the GOP support to clear full confirmation. 

On Monday, the Trump administration named Susan Monarez, acting director of the CDC, as its new nominee.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump not planning to fire Waltz after national security text chain leak
next post
Dem senator calls for Waltz, Hegseth to resign as Gabbard says no classified material shared in Signal

related articles

From Biden’s ‘war’ on gas prices to ‘small...

March 13, 2026

US diplomatic facility in Iraq struck by drone

March 13, 2026

171 million travelers face airport delays as Democrats’...

March 13, 2026

From Biden’s ‘war’ on gas prices to ‘small...

March 13, 2026

FDA launches new AI-powered system to track drug...

March 13, 2026

Cornyn reverses on filibuster stance to push Trump’s...

March 13, 2026

DAVID MARCUS: Sen Thune has no idea how...

March 13, 2026

Trump touts 5-0 sweep by endorsed candidates in...

March 13, 2026

US destroys 16 Iranian mine boats as Strait...

March 13, 2026

House GOP urges Trump to choke off Iran...

March 13, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • White House confronted on friendly reception of ‘existential threat’ Trump: ‘We are now in a different place’

    November 21, 2024
  • Constitution Party nominee aiming to help Trump, ‘destroy’ Democratic Party

    August 21, 2024
  • New report warns of growing national security threat to U.S. as China builds AI: ‘Significant and concerning’

    December 21, 2024
  • Trump and world leaders sign Gaza Board of Peace charter

    January 22, 2026
  • Elon Musk dubs himself the ”George Soros’ of the middle’

    November 14, 2024

Popular Posts

  • 1

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 2

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    CoreWeave eyes $1.5B bond raise to ease debt load following lacklustre IPO: report

    May 9, 2025

Categories

  • Economy (829)
  • Editor's Pick (8,376)
  • Investing (1,189)
  • Stock (981)

Latest Posts

  • Netanyahu’s meeting at White House moved amid Biden’s COVID recovery, Harris campaigning

    July 23, 2024
  • Nvidia’s CEO did a Q&A with analysts. What he said and what Wall Street thinks about it.

    March 21, 2025
  • Why Tesla stock is down over 2% on Monday

    February 23, 2026

Recent Posts

  • Trump admin warns 42 million Americans could lose food stamps as shutdown drags on

    October 27, 2025
  • CVS replaces CEO as profits, share price suffer

    October 19, 2024
  • DEROY MURDOCK: How RFK Jr. can help Trump make free speech great again

    September 1, 2024

Editor’s Pick

  • NASA’s ‘quiet’ supersonic jet completes first flight in potential breakthrough for commercial air travel

    October 29, 2025
  • Wayfair CEO likens home goods slowdown to 2008 financial crisis

    August 2, 2024
  • Lindsey Graham says there’s ‘strong consensus’ to protect Kurds as Syrian forces advance on territory

    January 25, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock